Viatris Inc. (VTRS): Price and Financial Metrics Recent IPO
VTRS Stock Price Chart Interactive Chart >
VTRS Price/Volume Stats
|Current price||$13.40||52-week high||$18.86|
|Prev. close||$13.28||52-week low||$12.94|
|Day high||$13.47||Avg. volume||11,164,448|
|50-day MA||$15.05||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||16.17B|
Viatris Inc. (VTRS) Company Bio
Viatris Inc. is a global healthcare company formed through the combination of Mylan and Upjohn. The company has a diverse portfolio including brand name products, key brands, branded and complex generics, biosimilars, and over the counter offerings across a wide range of therapeutic areas.
VTRS Price Forecast Based on DCF Valuation
|Current Price||DCF Fair Value Target:||Forecasted Gain:|
We started the process of determining a valid price forecast for Viatris Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Viatris Inc ranked in the 34th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for VTRS, they are:
- 24% of the company's capital comes from equity, which is greater than merely 4.72% of stocks in our cash flow based forecasting set.
- Viatris Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.45. This coverage rate is greater than that of only 23.22% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- The weighted average cost of capital for the company is 17. This value is greater than 98.72% stocks in the Healthcare sector that generate free cash flow.
|Terminal Growth Rate in Free Cash Flow||Return Relative to Current Share Price|
VTRS Latest News Stream
|Loading, please wait...|
VTRS Latest Social Stream
View Full VTRS Social Stream
Latest VTRS News From Around the Web
Below are the latest news stories about Viatris Inc that investors may wish to consider to help them evaluate VTRS as an investment opportunity.
Photo by wildpixel/iStock via Getty Images Rummaging through stocks that have recently hit 52-week lows can be a fun exercise. Most of the time you find candidates that deserve the pain that they are getting. Sometimes though, you find more interesting opportunities with an asymmetric risk-reward. The stock we are...
Photo by BWFolsom/iStock via Getty Images Introduction Viatris Inc.'s (VTRS) stock has been plummeting since its inception in late 2020, and despite its optimistic prospects for the future, I believe its share price will continue to decline in 2021. The company's growth in the past was due to aggressive acquisitions...
Every investor in Viatris Inc. ( NASDAQ:VTRS ) should be aware of the most powerful shareholder groups. Large companies...
Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday March 10, 2021. CEO Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will answer questions about the company at 3:00 p.m. ET.
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments
At a virtual meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS) will outline how the company expects to lead as a new kind of healthcare company with a unique and differentiated business model, high-quality operational platform and clear focus on ensuring its sustainability priorities and financial commitments are met.
VTRS Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!